Table of Contents

About Research

NPF is committed to leading collaborative, transformational research that leads to better treatments and a cure for these chronic diseases.

NPF is the largest nonprofit funder of psoriatic disease research in the world, with an investment strategy focused on treatment development and other approaches to improve health outcomes for everyone with psoriatic disease. NPF has invested over $20 million in grants and fellowships for psoriatic disease research in recent years.

NPF funds both early-stage research projects that demonstrate the potential to significantly increase our understanding of psoriatic diseases, as well as clinical and patient-centered research to improve patient outcomes. In addition to supporting research through our Grants and Fellowships program, NPF conducts research through partnerships with other institutions such as in the LITE study and is preparing for the first Foundation-led clinical study, an evaluation of the effect of educational intervention on treatment outcomes. NPF also works with legislators and policymakers to increase federal funding for psoriatic disease research.

Grants and Fellowship Programs

NPF advances research in psoriatic disease by maintaining a robust research program that contributes around $3 million to support psoriatic disease clinical research every year, through grants and fellowships, including support of research efforts in line with NPF’s 2020-2024 Strategic Plan, such as the Psoriasis Prevention Initiative and the PsA Diagnostic Test Grant.

The road to better treatments begins with basic research that answers fundamental questions about disease mechanisms. At this early stage, scientists need critical support to test their innovative ideas. NPF Discovery Grants can help advance basic science research and add to our understanding of psoriatic disease. Bridging the gap between the laboratory and the clinical practice, translational researchers do the costly, time-consuming work of converting discoveries from basic research into treatments that can be tested in clinical trials. NPF supports this bench-to-bedside research through our Translational Research Grants program. The NPF also remains committed to supporting those in the early stages of their career offering Early Career grants and Fellowships to support the retention of promising researchers in the psoriatic disease field.

Learn more about available NPF funding opportunities or donating to our research efforts.

Latest NPF Research News

Cartoon illustration of colorful images representing disease and science.

New Tools Take on an Old Disease

Data collection alone won’t find us a cure for psoriatic disease. First we have to figure out what the data are telling us.

Researcher Nehal Mehta smiles while wearing his white coat.

How NPF Empowers Psoriatic Disease Researchers

Nehal Mehta, M.D., is an NIH researcher with an impressive track record. NPF helped him get there.

Searching for Answers Through Science

Researcher Charlotte Hurabielle-Claverie, M.D., finds joy in unraveling the mysteries surrounding psoriatic disease.

Image of coronavirus molecule.

NPF Forms COVID-19 Task Force

This group of medical and scientific experts have collaborated to provide updated recommendations for people with psoriatic disease and will guide NPF in response to the ongoing pandemic and beyond.

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity Navigator

Copyright © 1996-2020 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.